{
  "seo": {
    "metaTitle": "Pharmacoeconomics in GCC: A Practical Guide 2025",
    "metaDescription": "Essential guide to pharmacoeconomic evaluation and HTA requirements across GCC markets.",
    "focusKeyword": "pharmacoeconomics GCC",
    "keywords": ["pharmacoeconomics", "HTA GCC", "health economics Middle East"]
  },
  "title": "Pharmacoeconomics in GCC Markets: A Practical Guide",
  "slug": {"current": "pharmacoeconomics-gcc-practical-guide"},
  "excerpt": "Navigate pharmacoeconomic requirements and HTA frameworks across UAE, Saudi Arabia, and Kuwait markets.",
  "readingTime": 12,
  "tags": ["Pharmacoeconomics", "HTA", "GCC Markets"],
  "body": [
    {
      "_type": "block",
      "style": "normal",
      "children": [{"_type": "span", "text": "Pharmacoeconomic evaluation is increasingly critical for market access in GCC countries..."}]
    }
  ],
  "faq": [
    {
      "question": "Do GCC countries require pharmacoeconomic dossiers?",
      "answer": "While not universally mandated, pharmacoeconomic evaluations are increasingly requested for high-cost therapies, particularly in UAE and Saudi Arabia."
    }
  ],
  "ctaSection": {
    "title": "Need Pharmacoeconomic Expertise?",
    "description": "We develop GCC-compliant pharmacoeconomic models and HTA dossiers.",
    "buttonText": "Learn More",
    "buttonUrl": "https://bionixus.com/services/pharmacoeconomics"
  }
}
